Navigation Links
AML patients have high response rate with vorinostat added to treatment
Date:12/12/2011

SAN DIEGO - Adding a drug that activates genes to frontline combination therapy for acute myeloid leukemia resulted in an 85 percent remission rate after initial treatment, researchers at The University of Texas MD Anderson Cancer Center reported at the 53rd Annual Meeting of the American Society of Hematology.

Results of the Phase II clinical trial of 75 patients set the stage for a national Phase III clinical trial of the new combination compared to standard-of-care frontline combinations used at MD Anderson and elsewhere, said study leader Guillermo Garcia-Manero, M.D., professor in MD Anderson's Department of Leukemia.

Study patients received the drug vorinostat, known commercially as Zolinza, a histone deacetylase inhibitor, in addition to the chemotherapy drug cytarabine and idarubicin, an anthracycline antibiotic commonly used as chemotherapy.

"The overall response rates are encouraging, and most higher risk patients did very well," Garcia-Manero said. He will be the principal investigator of the Phase III trial, which will be conducted through the National Cancer Institute's Cooperative Oncology Groups.

Vorinostat activates suppressed genes by protecting acetyl chemical groups that adhere to histone proteins, which are connected to DNA like beads on a string. Acetylated histones make genes more accessible for transcription, so vorinostat presumably works by reactivating blocked tumor-suppressing genes.

According to the NCI's Surveillance Epidemiology and End Results database, about 14,000 new cases of AML are diagnosed annually in the United States and the disease kills about 9,000 people each year. AML is characterized by swift proliferation of immature white blood cells in the blood and bone marrow that crowds out normal cells, leaving patients exposed to infection, severe anemia and bleeding.

High response for higher risk patients

Overall, 57 patients achieved complete remiss
'/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-516-4855
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. ICU Patients at Risk for Rare Heart Rhythm Problem
2. Young patients with chronic illnesses find relief in acupuncture
3. For Some Breast Cancer Patients, Shorter Radiation Works Well
4. New Study Uses Adult Stem Cells in Effort to Save Limbs of Patients with Peripheral Arterial Disease
5. Patients with Lethal Lung Disease Finally Receive Recognition by Social Security Administration
6. Behavioral therapy improves sleep and lives of patients with pain
7. Protecting patients: Study shows that Johns Hopkins flu vaccination rates twice national average
8. MSU researcher linking breast cancer patients with alternative therapies
9. New American Heart Association Survey Finds Heart Disease and Stroke Patients Face Significant Barriers in Obtaining Quality, Affordable Care
10. Fishy Smell May Keep Patients From Diabetes Drug
11. AGA offers new recommendations for CRC surveillance for certain patients with IBD
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
AML patients have high response rate with vorinostat added to treatment
(Date:9/1/2014)... New York (PRWEB) September 01, 2014 ... room in a hospital for performing surgical operations. An ... as operating tables, surgical booms, operating room lights, imaging ... According to a report by Transparency Market Research, a ... is expected to reach USD 4.5 billion by 2019. ...
(Date:9/1/2014)... Dennis Thompson HealthDay Reporter ... Ebola drug previously given to two American aid workers successfully ... in laboratory tests, researchers report. The drug, ZMapp, prompted ... they didn,t get the medication until five days after infection. ... who were days or even hours away from death, said ...
(Date:9/1/2014)... Washington, D.C. (PRWEB) September 01, 2014 ... is pleased to announce that Dawn Bazarko, DNP, MPH, ... become Fellows of the American Academy of Nursing. They ... PhD, MBA, RN-BC, CCM, FACHE, whose induction we reported ... on October 18, 2014, during the 2014 American Academy ...
(Date:9/1/2014)... Parties involved in federally-filed Tylenol lawsuits ... status conference in September, where issues related to claims ... Eastern District of Pennsylvania, Bernstein Liebhard LLP reports. ... on the Court’s website, the meeting is scheduled to ... This is the latest of several Tylenol conferences that ...
(Date:9/1/2014)... Denver, Colorado (PRWEB) August 31, 2014 ... Now, an online resource and community that gives members ... image editing resources. , This online resource aims to ... tattoo, as well as artists who are looking for ... , Learn more about Tattoo Me Now by visiting ...
Breaking Medicine News(10 mins):Health News:Operating Room Equipment Market Study 2019 by Transparency Market Research 2Health News:Operating Room Equipment Market Study 2019 by Transparency Market Research 3Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 2Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 3Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 2Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 3Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 4Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 2Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 3Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 4Health News:Tattoo Me Now Review Reveals Unique Ideas for Tattoo Designs 2
... go online with electronic health recordsNASHVILLE, Tenn., Jan. ... today that they and Cogdell Memorial Hospital are ... HMS to supply a fully integrated financial and ... Texas hospital closer to electronic health records (EHR) ...
... ATLANTA, Jan. 7 The TV Teacher, LLC(TM) announces ... select,New York City schools: Queens, Bronx, and Staten Island. ... Alphabet Beats(TM) was co-created,by Susan Ellis, a mother struggling ... write the alphabet. After an unsuccessful two years ...
... Jan. 7 David B. Snow Jr., chairman and chief ... ), is scheduled to address the 27th Annual JPMorgan Healthcare ... at the Westin St. Francis Hotel, San Francisco, will begin ... executives scheduled to attend are Richard J. Rubino, chief financial ...
... Boston Scientific Corporation (NYSE: BSX ) ... Health Care Conference in San Francisco.Jim Tobin, Chief Executive ... 14th, beginning at approximately 12:00 p.m. E.T. Following ... Financial Officer will join Mr. Tobin in a question ...
... Patent and Trademark Office (USPTO) has registered Guru ... relations strategy developed and honed by Tom Gable, ... The official USPTO language said the mark covered: ... of professional legal and accounting services, health care, ...
... Calif., Jan. 7 Agito Networks, Inc.(TM), ... mobility , today,announced that Technology Marketing Corporation,s ... named Agito Networks,RoamAnywhere(TM) Mobility Router(TM) as a ... , Agito Networks, ...
Cached Medicine News:Health News:Cogdell Memorial Hospital Partners with Healthcare Management Systems 2Health News:Cogdell Memorial Hospital Partners with Healthcare Management Systems 3Health News:New York Schools Receive Program for Children with Autism 2Health News:Medco CEO to Present at the 27th Annual JPMorgan Healthcare Conference 2Health News:Guru Program Pioneered by Tom Gable Receives Official Registration from USPTO 2Health News:Guru Program Pioneered by Tom Gable Receives Official Registration from USPTO 3Health News:Agito Networks' RoamAnywhere Mobility Router Wins Unified Communications Magazine's 2008 UC Excellence Award 2Health News:Agito Networks' RoamAnywhere Mobility Router Wins Unified Communications Magazine's 2008 UC Excellence Award 3Health News:Agito Networks' RoamAnywhere Mobility Router Wins Unified Communications Magazine's 2008 UC Excellence Award 4
(Date:8/29/2014)... Aug. 29, 2014 The Competitive Intelligence (CI) ... marketplace changes. CI leaders who adjust will succeed, and ... a new Best Practices, LLC study CI leaders from ... including: - Use secondary research whenever possible ... - Internal staff who are creative thinkers ...
(Date:8/29/2014)... , Aug. 29, 2014 Pomerantz LLP has ... or the "Company") (NASDAQ: EDAP ) and ... United States District Court, Southern District of ... on behalf of a class consisting of all persons ... 2013 and July 30, 2014, inclusive (the "Class Period"). This ...
(Date:8/29/2014)... DIEGO , Aug. 29, 2014   ... emerging biopharmaceutical company, announced today that Santosh Vetticaden, ... be leaving the Company, for personal reasons, in ... Chief Medical Officer of Aires Pharmaceuticals, which Mast ... former responsibilities as the Company,s interim Chief Medical ...
Breaking Medicine Technology:Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4
... Calif., March 1, 2012  Bionovo, Inc. (OTC Link Platform: BNVI.PK), ... safe and effective treatments for women,s health and cancer, today ... President, will be presenting at the Cowen and Company 32nd ... 5, 2012.  The event will be held at the Boston ...
... England, March 1, 2012 Some of the ... cutting thousands of medical sales jobs in order to slash ... the industry. Biopharmaceutical giants AstraZeneca were the first ... be axed in 2012. The company has already seen an ...
Cached Medicine Technology:Job Cuts from Major Pharmaceutical Firms Results in Tougher Competition, Says Advance Recruitment 2
The humidity chamber maintains a moist environment during immunostaining procedures as well as other laboratory procedures requiring controlled incubation steps....
Used to remove wrinkles from sections and for reorientating embedded tissue....
Prevents formation of microscopic ice crystals and sample distortion caused by slow freezing of hyperosmolar tissue samples in conventional cyrostats....
Liquichek Blood Gas Plus EGL Control is an aqueous product used to monitor the measurement of pH, pCO2, pO2, electrolytes, glucose and lactate (lactic acid)....
Medicine Products: